Company Search:
Advanced Search
Sponsored Links
RegeneRx Biopharmaceuticals, Inc. Company Snapshot
RegeneRx Biopharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares RegeneRx Biopharmaceuticals with three other companies in this sector in the United States: Amarillo Biosciences, Inc. (2018 sales of $77,724.00 ), Adhera Therapeutics Inc ($76,186.00 ), and Sangui Biotech International, Incorporated ($77,152.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
RegeneRx Biopharmaceuticals, Inc.
  Stock Performance Chart for RegeneRx Biopharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (2/14/2020): .25
(Figures in U.S. Dollars)
1 Week -6.7%   13 Weeks -6.7%  
4 Weeks 70.8%   52 Weeks 93.8%  
RegeneRx Biopharmaceuticals, Inc. Key Data:
  Ticker: RGRX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 69,667
(Year Ending Jan 2019).
Employees: 5
  Currency: U.S. Dollars Market Cap: 33,139,636
  Fiscal Yr Ends: December Shares Outstanding: 131,506,494
  Share Type: Common Closely Held Shares: 64,844,350
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.